Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

Nursing and Allied Health: WHO Drug Information [Relative to Diseases]

Online Learning

Welcome to the NSU CON-SAH Library

mesh

WHO Drug Information

World Health Organization | WHO Drug Information 2022
Citation
World Health Organization. (‎2022)‎. WHO Drug Information 2022, vol. 36, 3 [‎full issue]‎. WHO Drug Information, 36 (‎3)‎, 595 - 886. World Health Organization. https://apps.who.int/iris/handle/10665/363551. License: CC BY-NC-SA 3.0 IGO

Approved Drug Products with Therapeutic Equivalence Evaluations | Orange Book

FDA Orange Book

 

The publication, Approved Drug Products With Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the FD&C Act). The main criterion for the inclusion of any product is that the product is the subject of an application with an approval that has not been withdrawn for safety or effectiveness reasons. Inclusion of products in the Orange Book is independent of any current regulatory action being taken administratively or judicially against a drug product. In addition, the Orange Book contains therapeutic equivalence evaluations for approved multisource prescription drug products. These evaluations have been prepared to serve as public information and advice to state health agencies, prescribers, and pharmacists to promote public education in the area of drug product selection and to foster containment of health care costs. Therapeutic equivalence evaluations in this publication are not official FDA actions affecting the legal status of products under the FD&C Act. 

The Orange Book downloadable data files are updated monthly. We make every effort to prevent errors and discrepancies in the Approved Drug Products data files; however, if you wish to report an error or discrepancy in drug data, please send a brief description of the problem to orangebook@fda.hhs.gov.

General questions related to the drug data in these files should be directed to the Center for Drug Evaluation and Research, Division of Drug Information druginfo@fda.hhs.gov.

Citation:

 

 

Thank you for visiting our Libraries!

Visit Our Libraries

Northwestern State University of Louisiana Libraries    |   Watson Memorial Library   |  913 University Pkwy    | Natchitoches LA 71457
 

  |    Shreveport Education Center Library   |Eugene P. Watson Memorial Library    |    NSU Leesville Library 

   |  Prince Music Media Library